Doç. Dr. Mesut GÖÇER

1. Comparative efficacy and safety of G-CSF alone versus G-CSF combined with different doses of cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma

GÖÇER M., KURTOĞLU E.

Transfusion and Apheresis Science , cilt.65, sa.4, 2026 (SCI-Expanded, Scopus)

2. Bosutinib and Membranous Nephropathy in Chronic Myeloid Leukemia: Coincidence or Drug-Related İnjury? Bosutınıb y Nefropatía Membranosa en Leucemıa Mıeloıde Crónıca: ¿Coıncıdencıa o Lesıón Relacionada con el Fármaco?

Yıldırım Ş., İnci A., Kılıçaslan A., Coşkuner S. Ü., GÖÇER M.

Revista de Nefrologia, Dialisis y Trasplante , cilt.46, sa.2, ss.99-105, 2026 (SCI-Expanded, Scopus)

3. Effects of Splenectomy on Natural Killer Cell Levels in β-Thalassemia Major Patients

Kurtoğlu A. U., Uğur S., GÖÇER M., KURTOĞLU E.

Journal of Clinical Laboratory Analysis , cilt.38, sa.9, 2024 (SCI-Expanded, Scopus)

4. Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis

Guven S., YAVUZ A. B., Yucel E. E., Karatas A. F., Ozsan G. H., Demirkan F., et al.

Eurasian Journal of Medicine and Oncology , cilt.7, sa.1, ss.49-56, 2023 (ESCI, Scopus, TRDizin)

5. Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study

AÇAR İ. H., Guner S. I., Ak M. A., GÖÇER M., Ozturk E., Atalay F., et al.

Mediterranean Journal of Hematology and Infectious Diseases , cilt.14, sa.1, 2022 (SCI-Expanded, Scopus)

6. Prognostic significance of hematogone presence after autologous stem cell transplantation in patients with multiple myeloma

GÖÇER M., KURTOĞLU E.

Cytometry Part B - Clinical Cytometry , cilt.100, sa.6, ss.645-651, 2021 (SCI-Expanded, Scopus)

7. Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis

GÖÇER M., KURTOĞLU E.

Therapeutic Apheresis and Dialysis , cilt.25, sa.5, ss.697-703, 2021 (SCI-Expanded, Scopus)

8. Effect of the ABO blood groups on the development, clinical features and survival of multiple myeloma

GÖÇER M., KURTOĞLU E.

Memo - Magazine of European Medical Oncology , cilt.14, sa.3, ss.235-240, 2021 (ESCI, Scopus)

9. Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?

GÖÇER M., KURTOĞLU E.

Journal of Clinical Apheresis , cilt.36, sa.3, ss.332-339, 2021 (SCI-Expanded, Scopus)

10. Ruxolitinib use in myelofibrosis patients: the single center experience and the relationship between JAK-2 allele burden and Ruxolitinib response Myelofibrozis hastalarında Ruxolitinib kullanımı: tek merkez deneyimi ve JAK-2 allel yükü ile Ruxolitinib yanıtı arasındaki ilişki

GÖÇER M., KURTOĞLU E.

Pamukkale Medical Journal , cilt.14, sa.2, ss.322-329, 2021 (Scopus, TRDizin)

11. Comparison of Bone Marrow Involvement with Bone Marrow Biopsy and PET–CT and Evaluation of Any Effects on Survival in Patients Diagnosed with Hodgkin and Non-Hodgkin Lymphoma

GÖÇER M., KURTOĞLU E.

Indian Journal of Hematology and Blood Transfusion , cilt.37, sa.1, ss.52-59, 2021 (SCI-Expanded, Scopus)

12. Clinical Significance of Increased FDG Uptake in the Waldeyer Ring and the Nasopharynx Region Identified by PET-CT in Postchemotherapy Follow-up in Patients With Lymphoma: When Should We Perform Biopsy?

KURTOĞLU E., GÖÇER M.

Clinical Lymphoma, Myeloma and Leukemia , cilt.20, sa.12, ss.830-835, 2020 (SCI-Expanded, Scopus)

13. Safety and efficacy analysis of ibrutinib in 32 patients with CLL and various B-cell lymphomas: Real-world data from a single-center study in Turkey

GÖÇER M., KURTOĞLU E.

Blood Research , cilt.55, sa.4, ss.206-212, 2020 (ESCI, Scopus)

14. Thrombotic thrombocytopenic purpura cases and consumption of large quantities of energy drink: Related or coincidence?

GÖÇER M., ILTAR U., Aykaş F., Aslan V., Nizam I., Çelik M., et al.

Acta Haematologica , cilt.143, sa.2, ss.176-180, 2020 (SCI-Expanded, Scopus)

15. False elevations of vitamin B12 levels due to assay errors in a patient with pernicious anemia

ILTAR U., GÖÇER M., KURTOĞLU E.

Blood Research , cilt.54, sa.2, ss.149-151, 2019 (Scopus)

16. Kaposi sarcoma following autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia

ILTAR U., Aslan V., GÖÇER M., Aykac F., Nizam İ., Çelik M., et al.

Memo - Magazine of European Medical Oncology , cilt.12, sa.1, ss.99-102, 2019 (Scopus)

Doç. Dr. Mesut GÖÇER

Yayınlar & Eserler

1. Comparative efficacy and safety of G-CSF alone versus G-CSF combined with different doses of cyclophosphamide for peripheral blood stem cell mobilization in patients with multiple myeloma

2. Bosutinib and Membranous Nephropathy in Chronic Myeloid Leukemia: Coincidence or Drug-Related İnjury? Bosutınıb y Nefropatía Membranosa en Leucemıa Mıeloıde Crónıca: ¿Coıncıdencıa o Lesıón Relacionada con el Fármaco?

3. Effects of Splenectomy on Natural Killer Cell Levels in β-Thalassemia Major Patients

4. Clinical Outcomes and Treatment Patterns of Primary Central Nervous System Lymphoma: Multicenter Retrospective Analysis

5. Impact of COVID-19 on Outcomes of Patients with Hematologic Malignancies: A Multicenter, Retrospective Study

6. Prognostic significance of hematogone presence after autologous stem cell transplantation in patients with multiple myeloma

7. Effect of prophylactic leukapheresis on early mortality and overall survival in acute leukemia patients with hyperleukocytosis

8. Effect of the ABO blood groups on the development, clinical features and survival of multiple myeloma

9. Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma?

10. Ruxolitinib use in myelofibrosis patients: the single center experience and the relationship between JAK-2 allele burden and Ruxolitinib response Myelofibrozis hastalarında Ruxolitinib kullanımı: tek merkez deneyimi ve JAK-2 allel yükü ile Ruxolitinib yanıtı arasındaki ilişki

11. Comparison of Bone Marrow Involvement with Bone Marrow Biopsy and PET–CT and Evaluation of Any Effects on Survival in Patients Diagnosed with Hodgkin and Non-Hodgkin Lymphoma

12. Clinical Significance of Increased FDG Uptake in the Waldeyer Ring and the Nasopharynx Region Identified by PET-CT in Postchemotherapy Follow-up in Patients With Lymphoma: When Should We Perform Biopsy?

13. Safety and efficacy analysis of ibrutinib in 32 patients with CLL and various B-cell lymphomas: Real-world data from a single-center study in Turkey

14. Thrombotic thrombocytopenic purpura cases and consumption of large quantities of energy drink: Related or coincidence?

15. False elevations of vitamin B12 levels due to assay errors in a patient with pernicious anemia

16. Kaposi sarcoma following autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)